Safety for biosimilars: Strategic pharmacovigilance solutions
by
34 34 people viewed this event.
The webinar will focus on the distinctive challenges of biosimilar development and requiring keen pharmacovigilance. Industry experts Ivana Lisec and Sara Lipovac will guide attendees on building scalable pharmacovigilance strategies, leveraging advanced technologies, and understanding regulatory landscapes—all crucial for maintaining safety and efficacy in biosimilars.